Trials / Completed
CompletedNCT00730977
A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
A Pilot Study to Investigate the Tolerability of Inhaled Dry Powder Mannitol (IDPM) Administered Via a Novel Dry Powder Inhaler Device in Healthy Individuals and Subjects With Bronchiectasis.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Syntara · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A novel dry powder inhaler device will be used to administer mannitol to healthy subjects and subjects with bronchiectasis in single doses higher than previously given.The main objective is to assess tolerability of these doses using the new device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dry powder inhaled mannitol | single doses of 40 mg, 70 mg and 100 mg |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2008-08-08
- Last updated
- 2009-09-18
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00730977. Inclusion in this directory is not an endorsement.